GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CBR1, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD2, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MET, PIK3CA, PIK3CB, PPARA, PTGES, PTGS1, PTGS2 |
14.0877 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGES, PTGS1, PTGS2 |
12.9521 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALDH2, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, FUT7, HSD17B3, HTR2B, PIK3CA, PIM1, PPARA, PTGES, PTGS1, PTGS2, TYR, XDH |
12.9521 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGES, PTGS1, PTGS2 |
12.9521 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGES, PTGS1, PTGS2 |
12.5682 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, APP, AR, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, ESRRA, F3, FABP3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MMP12, MMP2, MMP9, PGR, PIM1, PTGES, PTGS1, PTGS2, RELA, SLC6A4, SRC, TERT, XDH |
11.2511 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR2A, HTR2B, HTR6, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SRC, TERT, XDH |
11.1939 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR2A, HTR2B, HTR6, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SRC, TERT, XDH |
11.1747 |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CA2, CA9, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HTR2A, HTR2B, HTR5A, IGF1R, KCNH2, KDR, MMP2, MMP9, NR3C1, PIK3CA, PPARA, PTGES, PTGS2, RELA, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
10.8889 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.7966 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGES, PTGS1, PTGS2 |
10.3954 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, ESR1, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
10.0831 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGES, PTGS1, PTGS2 |
10.0831 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, PPARA, PTGES, PTGS1, PTGS2 |
10.0688 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.0204 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, F3, FABP3, FABP4, FLT3, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2B, HTR7, KCNH2, KDR, MAOA, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SLC6A2, SLC6A4, SRC, TERT, XDH |
9.91499 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, HSD17B2, HTR5A, IGF1R, MMP2, MMP9, NR3C1, PIK3CA, PPARA, PTGES, PTGS2, RELA, RORC, SLC6A4, SRC, TYR |
9.67795 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2B, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, TYR, XDH |
9.67449 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD2, FABP3, FABP4, FUT7, MET, PIK3CA, PIK3CB, PPARA, PTGES, PTGS1, PTGS2 |
9.35896 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APP, AR, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FLT3, HTR5A, NR3C1, PTGES, PTGS2, RELA, RORC, SLC6A4, SRC, TYR |
9.35896 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CYP1B1, DRD2, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MAP2K1, MAP3K7, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SRC, XDH |
9.26304 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALDH2, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MAOA, NQO2, PTGS1, PTGS2, TYR, XDH |
9.24259 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HTR5A, IGF1R, KDR, MMP2, NR3C1, PIK3CA, PPARA, PTGES, PTGS2, RELA, RORC, SLC6A4, SRC, TYR |
9.15517 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALDH2, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2B, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, TYR, XDH |
8.80182 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
8.80182 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SRC, TERT, XDH |
8.80182 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, MAP3K7, NR3C1, PGR, PIM1, PPARA, RELA, RORC, SRC |
8.78412 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, XDH |
8.34536 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP2D6, NQO2, PTGS1, RORC |
8.34536 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
8.19555 |
[BP] GO:0033993 |
response to lipid
|
AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD17B2, HTR5A, NR3C1, PTGES, PTGS2, RELA, RORC, SLC6A4, SRC, TYR |
7.8142 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
7.77164 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SRC, XDH |
7.58546 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SLC6A4, SRC, TERT, XDH |
7.51107 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, PTGES, PTGS2, RELA, SRC, TERT |
7.44662 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SLC6A4, SRC, TERT, XDH |
7.3645 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, PPARA, PTGES, PTGS1, PTGS2 |
7.22878 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALDH2, ALOX15, APP, CES1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, HSD17B3, HTR1A, MAOA, TYR |
7.21186 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA6, CA9, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MMP12, MMP2, MMP9, NR3C1, PIK3CA, PIK3CB, PPARA, PTGES, PTGS1, PTGS2, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
7.19114 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, AR, CDC25B, CSNK2A1, DRD2, DRD3, ESR1, F3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2, RELA, TERT |
7.09398 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4, SRC |
7.05375 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, ADRA2A, AKR1B1, APP, AR, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FABP3, FLT3, HTR5A, IGF1R, MMP2, NR3C1, PPARA, PTGS2, RELA, SLC6A4, SRC |
7.03359 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, ESRRA, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SRC, TERT, XDH |
7.00623 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, AXL, CA9, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, KCNH2, KDR, NR3C1, PTGS2, RELA, SLC6A2, SLC6A4, SRC |
6.92321 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2A |
6.89941 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, ADRA2A, AKR1B1, AR, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HTR5A, NR3C1, PPARA, PTGS2, RELA, SLC6A4, SRC |
6.89941 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, XDH |
6.88858 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, ADRA2A, ALOX15, APP, AR, DRD2, FLT3, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, PIK3CB, PTPN1, SRC, XDH |
6.88858 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA9, CACNA1C, CBR1, CDC25B, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, HSD17B3, HTR2A, HTR2B, HTR5A, KDR, MAP2K1, MET, MMP2, MMP9, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RELA, RORC, SIGMAR1, SLC6A4, SRC, TERT, TYR |
6.88858 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ADRA2A, ALOX15, APP, AR, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
6.88858 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ADRA2A, ALOX15, APP, AR, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
6.88858 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
6.84504 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
6.84504 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
6.78923 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 |
6.78588 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, AR, AXL, CACNA1C, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRB, F3, FABP4, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, IGF1R, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RELA, RORC, SLC6A2, SLC6A4, SRC, TYR |
6.74604 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, ADRA2A, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, XDH |
6.62521 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
6.60883 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, ADRA2A, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RELA, RORC, SRC, TERT, XDH |
6.59527 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
6.58661 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, HCAR2, HTR2A, HTR2B, KDR, PIK3CB, PTGS2, SRC |
6.51538 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.46497 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.46497 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, ADRA2A, ALOX15, APP, AR, CDC25B, DRD2, ESRRB, FLT3, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
6.35861 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSD17B3, KDR, MAP2K1, PIK3CA, PPARA, RELA, SRC, TYR |
6.34468 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, ADRA2A, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, XDH |
6.32919 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, HTR2B, IGF1R, KDR, MAP2K1, MET, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, RELA, SIGMAR1, SRC, TERT, XDH |
6.24736 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, HTR2B, IGF1R, KDR, MAP2K1, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RELA, SIGMAR1, SRC, TERT, XDH |
6.20947 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, ADRA2A, ALOX15, APP, AR, AURKB, CDC25B, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RELA, RORC, SRC, TERT, XDH |
6.19276 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APP, AR, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, HCAR2, HTR1A, HTR2A, HTR2B, IGF1R, KCNH2, KDR, MAP2K1, MET, MMP12, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SLC6A4, SRC, TERT |
6.19276 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, ADRA2A, ALOX15, APP, AR, CDC25B, DRD2, FLT3, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.98182 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7, SLC6A4 |
5.97336 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4, SRC |
5.97336 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, ALDH2, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, MAOA |
5.93305 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AXL, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, FLT3, HTR2A, HTR2B, KCNH2, MET, PIK3CA, PIK3CB, SRC, TERT |
5.91989 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, HTR2A, HTR2B, KDR, SRC |
5.91934 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
5.90984 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, APP, AR, AXL, CA1, CA2, CACNA1C, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP2, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SIGMAR1, SRC |
5.83707 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MMP2, MMP9, NR3C1, PIK3CA, PTGS2, RELA, RORC, SLC6A4, SRC, TERT |
5.83707 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, ADRA2A, ALOX15, APP, AR, CDC25B, DRD1, DRD2, ESRRB, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
5.72692 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, HTR2B, IGF1R, KDR, MAP2K1, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, RELA, SIGMAR1, SRC, TERT, XDH |
5.72473 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ADRA2A, ALOX15, APP, AR, CDC25B, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
5.71336 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3, PTGS2, SLC6A4 |
5.69942 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CES1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, PIK3CA, PIK3CB, PTGES, PTGS1, PTGS2 |
5.68782 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, ADRA2A, ALOX15, APP, AR, DRD2, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, PIK3CB, PTPN1, SRC, XDH |
5.67889 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ADRA2A, ALOX15, APP, AR, CDC25B, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
5.65194 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
5.53408 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.48022 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.48022 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR6, HTR7 |
5.4053 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
5.36757 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, DRD3, FABP3, FLT3, HCAR2, HTR2A, HTR2B, PPARA, PTGS2, RORC, SRC |
5.36757 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, ADRA2A, AKR1B1, APP, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, HTR2A, HTR2B, KCNH2, MET, PIK3CA, PIK3CB |
5.34339 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A, PTGS2, SLC6A4 |
5.34339 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, PTGS2, SLC6A4 |
5.33546 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, PTGS2, SLC6A4 |
5.33546 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, PIM1, PPARA, PTGES, PTGS1, PTGS2, TYR |
5.28914 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, ADRA2A, ALOX15, APP, AR, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.22603 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, ALOX15, APP, AXL, CA2, CA7, CACNA1C, CYP19A1, DRD1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, KCNH2, MAP2K1, MMP12, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SLC6A4, SRC, TERT |
5.16478 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2, HSD17B3 |
5.03537 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, ADRA2A, APP, AR, AXL, CA2, CYP1B1, DRD2, DRD3, ESRRB, F3, HCAR2, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIM1, PTGS2, RELA, SRC, TERT |
4.99775 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
4.99036 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
4.94333 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, APP, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSD17B3, HTR5A, KDR, MAP2K1, MMP9, PGR, PIK3CA, PIM1, PPARA, PTGS2, RELA, RORC, SIGMAR1, SRC, TYR |
4.91773 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, NR3C1, PIK3CA, PTGS2, RELA, RORC, SLC6A4, SRC |
4.91612 |
[BP] GO:0007193 |
None
|
ADORA1, ADRA2A, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
4.86743 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD1, DRD2, DRD3, HTR1A, MAOA, TYR |
4.79159 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.78616 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
4.74589 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2B, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPN1, RELA, RORC, SRC, TERT, TYR, XDH |
4.69731 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CYP1B1, DRD1, ESR1, IGF1R, MMP2, MMP9, NR3C1, PIK3CA, PTGS2, RELA, RORC, SLC6A4, SRC |
4.69398 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2, PTGS2 |
4.69158 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, DRD3, ESR1, HTR7, PGR, PPARA, RORC, SLC6A4, SRC |
4.68013 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APP, AR, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, NR3C1, PTGS2, RORC, SLC6A4, SRC |
4.67643 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, PIM1, PPARA, PTGES, PTGS1, PTGS2, TYR |
4.67403 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RELA, SRC, TERT |
4.6556 |
[BP] GO:0019371 |
None
|
CBR1, PTGES, PTGS1, PTGS2 |
4.61954 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA1A, ADRA2A, ALOX15, APP, AR, CDC25B, CSNK2A1, DRD2, ESR1, F3, FLT3, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SRC, XDH |
4.6047 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, AKR1B10, ALDH2, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, HCAR2, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPN1, RELA, RORC, SIGMAR1, SLC6A2, SLC6A4, SRC, TERT, TYR, XDH |
4.59016 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, PIM1, PPARA, PTGES, PTGS1, PTGS2, TYR |
4.57396 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, ADRA2A, AR, DRD1, DRD2, DRD3, ESR1, ESR2, HTR2A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, RELA, SLC6A4, SRC, TERT, XDH |
4.57042 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, HTR2B, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, RELA, SRC, TERT |
4.56675 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, ADRA2A, AR, DRD1, DRD2, DRD3, ESR1, ESR2, HTR2A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, RELA, SLC6A4, SRC, TERT, XDH |
4.55234 |
[BP] GO:0007200 |
None
|
ADRA1A, ADRA2A, DRD1, DRD2, ESR1, HTR2A, HTR2B |
4.52225 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, KCNH2, PPARA, SLC6A2, SLC6A4 |
4.47362 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, ADRA2A, APP, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, HTR1A, HTR2A, KCNH2, MMP9, PTGS2, SLC6A4 |
4.46379 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, DRD3, HTR1A, MAOA |
4.45356 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA1A, ADRA2A, ALOX15, APP, AR, CDC25B, DRD2, FLT3, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
4.38493 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, DRD1, DRD2, DRD3, HTR2A, HTR2B, MMP2, PPARA, PTGS2, RELA, SLC6A4, SRC, TERT, TYR |
4.34552 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MET, MMP12, NR3C1, PGR, PPARA, PTGS2, RELA, RORC, SRC, TERT |
4.31514 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
4.31334 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HCAR2, HTR2A, HTR2B, IGF1R, KCNH2, KDR, MAP2K1, MET, MMP12, MMP9, NR3C1, PGR, PIK3CA, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, XDH |
4.28328 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
4.28328 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HTR2B, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPN1, RELA, RORC, SRC, TERT, TYR, XDH |
4.26878 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.26234 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, DRD2 |
4.25695 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, DRD2, DRD3, HTR2A, KCNH2, MMP9, PTGS2 |
4.25695 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9, PTGES, PTGS2, TERT |
4.25293 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, HTR1A, MAOA, PTGS2, SLC6A2, SLC6A4 |
4.22708 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, ALDH2, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, FABP3, FABP4, FUT7, MAOA, MMP1, MMP12, MMP2, MMP9, PIK3CB, SRC, XDH |
4.22616 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MMP2, MMP9, NR3C1, PIK3CA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT |
4.21669 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
4.20952 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, ALOX15, APP, DRD2, HTR2A, HTR2B, KDR, MAP2K1, SRC |
4.20393 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AR, AXL, CA2, CACNA1C, CYP1B1, DRD2, DRD3, ESR1, ESRRA, ESRRB, F3, HCAR2, HTR2A, HTR2B, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIK3CA, PIM1, PTGS2, RELA, SLC6A4, SRC, TERT, XDH |
4.19325 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HTR2A, HTR2B, IGF1R, KCNH2, KDR, MAP2K1, MET, MMP12, MMP9, NR3C1, PIK3CA, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, XDH |
4.16841 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, CES1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, RELA, SLC6A4, SRC |
4.14396 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, FLT3, HTR2A, HTR2B, MAP2K1, MAP3K7, PIK3CB, PTPN1, SRC |
4.1121 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, ESR2, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SRC, TERT, XDH |
4.11053 |
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, AR, DRD2, DRD3, PPARA, PTGS1, PTGS2 |
4.10652 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
4.10652 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA1A, ADRA2A, APP, AR, AURKB, CDC25B, DRD2, ESR1, ESR2, F3, FLT3, HTR2A, HTR2B, MAP2K1, MAP3K7, MET, MMP9, PIK3CA, PIK3CB, PTPN1, RELA, SRC, TERT, XDH |
4.09127 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, RELA, SRC, TERT |
4.04097 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, FLT3, HTR2A, HTR2B, IGF1R, MAP2K1, MAP3K7, PIK3CB, PTPN1, SRC |
4.01826 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, APP, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, FABP3, HTR2A, HTR2B, KCNH2, PIK3CB |
4.01175 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, CA2, DRD1, DRD2, DRD3, ESR1, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, PIK3CA, PIK3CB, SIGMAR1, SRC |
3.99996 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, APP, AXL, CA2, CYP19A1, DRD1, DRD2, DRD3, HCAR2, HTR2B, KCNH2, MMP12, PTGS2, SLC6A4, SRC, TERT |
3.99996 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, F3, MET, PIK3CA, PIK3CB, SRC, XDH |
3.99164 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, ALOX15, APP, DRD2, HTR2A, HTR2B, KDR, MAP2K1, PTPN1, SRC |
3.99151 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA1A, ADRA2A, ALOX15, APP, AR, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SRC, XDH |
3.99151 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX15, ALOX5, PTGES, PTGS1, PTGS2 |
3.98816 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, ADRA2A, AKR1B1, AXL, CACNA1C, CYP1B1, DRD1, DRD2, DRD3, HTR2A, HTR2B, HTR5A, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIK3CA, PIK3CB, PTPN1, RELA, SRC |
3.98616 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AR, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, XDH |
3.97265 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, ADRA2A, ALOX15, APP, AR, CDC25B, DRD2, ESR1, F3, FLT3, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.97265 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, IGF1R, MAP2K1, MET, MMP12, NR3C1, PGR, PPARA, PTGS2, RELA, RORC, SRC, TERT |
3.9637 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, APP, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
3.9637 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, KCNH2, KDR, NR3C1, PTGS2, RELA, SRC |
3.89823 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, FLT3, HTR2A, HTR2B, MAP2K1, MAP3K7, PIK3CA, PIK3CB, PTPN1, SRC |
3.86636 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, APP, CDC25B, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MAP2K1, MAP3K7, PIK3CA, PIK3CB, PTPN1, SRC |
3.84842 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RELA, SRC, TERT, XDH |
3.83891 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, APP, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
3.83891 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, ALDH2, CYP1A2, CYP2A6, CYP2C19, CYP2D6, MAOA |
3.83859 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, APP, CACNA1C, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
3.82294 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, HCAR2, PIK3CB, PTGS2 |
3.78038 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET, PIK3CA |
3.7451 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MAP2K1, MAP3K7, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RELA, SRC, TERT, XDH |
3.7451 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, ADRA2A, ALOX15, DRD1, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
3.7249 |
[BP] GO:0051952 |
None
|
ADORA1, ADRA2A, DRD1, DRD2, DRD3, HTR2A |
3.7249 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3, MAOA |
3.69915 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3, MAOA |
3.69915 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
3.69915 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2C19, CYP2D6 |
3.67694 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, NR3C1, PGR, SRC |
3.66947 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, ADRA2A, CACNA1C, DRD1, DRD2, DRD3, HTR2B, HTR5A, KDR |
3.66321 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, ADRA2A, ALOX15, AR, CYP19A1, DRD1, DRD2, DRD3, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, SRC, TERT, XDH |
3.65618 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, APP, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
3.65077 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, PPARA, PTGS2, SRC |
3.65077 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
3.65077 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, FLT3, HTR2A, HTR2B, MAP2K1, MAP3K7, PIK3CA, PIK3CB, PTPN1, SRC |
3.60644 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
3.58859 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, FLT3, HTR2B, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIK3CA, PIM1, SRC |
3.58859 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, APP, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, KCNH2, PIK3CB |
3.57908 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, APP, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
3.52111 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, APP, CDC25B, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MAP2K1, MAP3K7, PIK3CA, PIK3CB, PTPN1, SRC |
3.49594 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PTGES, PTGS2, RELA, SLC6A4, SRC |
3.44593 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DRD1, DRD2, DRD3, FABP3, FLT3, IGF1R, MMP2, PPARA, PTGS2, RELA, SLC6A4, SRC, TYR |
3.41934 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SLC6A4, SRC, TERT |
3.34867 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.33709 |
[BP] GO:0019933 |
None
|
ADRA1A, ADRA2A, DRD1, DRD2, DRD3, HTR5A |
3.31277 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, ADRA2A, CACNA1C, CYP19A1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, MMP12, SLC6A4, SRC |
3.29326 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, KCNH2, PIK3CA |
3.28993 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APP, AR, DRD1, ESR1, FLT3, IGF1R, MMP2, NR3C1, PTGS2, RELA, SLC6A4, SRC |
3.28936 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.28315 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.28315 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, ESR1, F3, FABP4, KDR, MAP2K1, MET, MMP12, PPARA, PTGS2, RELA |
3.28315 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRA2A, AURKB, CDC25B, DRD2, FLT3, HTR2A, HTR2B, MAP2K1, MAP3K7, PIK3CA, PIK3CB, PTPN1, SRC |
3.28315 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SLC6A4, SRC, TERT |
3.26185 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, APP, CYP19A1, DRD2, ESR1, F3, FABP4, IGF1R, MAP2K1, MAP3K7, MET, MMP12, MMP2, PPARA, PTGS2, PTPN1, RELA, SRC, TERT, XDH |
3.24834 |
[BP] GO:0006693 |
None
|
CES2, PTGES, PTGS1, PTGS2 |
3.21769 |
[BP] GO:0006692 |
None
|
CES2, PTGES, PTGS1, PTGS2 |
3.21769 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, HTR2A, IGF1R, MAP2K1, MET, MMP12, NR3C1, PGR, PPARA, PTPN1, RELA, RORC, SRC, TERT |
3.21769 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, AR, CACNA1C, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, KCNH2, PGR, SLC6A2 |
3.20177 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, APP, AR, AURKB, CSNK2A1, CYP2D6, DRD2, DRD3, ESR1, ESR2, ESRRA, FABP4, HCAR2, HTR2B, IGF1R, KDR, MAP2K1, MET, MMP12, MMP9, NR3C1, PGR, PIK3CA, PPARA, PTGS2, PTPN1, RELA, RORC, SRC, TERT, XDH |
3.18185 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, APP, AR, CYP1B1, DRD2, FABP3, MAP2K1, PTGES, PTGS2, SLC6A4, TERT, XDH |
3.17053 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MAP2K1, MAP3K7, PIK3CA, PIK3CB, PTPN1, SRC |
3.17053 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, DRD2, DRD3, ESR1, IGF1R, MET, MMP9, PTGS2, PTPN1, RELA, SRC, XDH |
3.16734 |
[BP] GO:0043266 |
None
|
ADORA1, ADRA2A, DRD1, DRD2, HTR2A, KCNH2 |
3.16146 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, FLT3, HTR2A, HTR2B, MAP2K1, MAP3K7, PIK3CB, PTPN1, SRC |
3.16101 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.13414 |
[BP] GO:0019935 |
None
|
ADRA1A, ADRA2A, DRD1, DRD2, DRD3, HTR5A |
3.11605 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3, MAOA |
3.10233 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, HTR2A, PTGS2 |
3.09413 |
[BP] GO:0006936 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, KCNH2, PIK3CA |
3.09183 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, APP, DRD1, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
3.07535 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DRD1, DRD2, DRD3, FABP3, FLT3, IGF1R, MMP2, PPARA, PTGS2, RELA, SLC6A4, SRC, TYR |
3.07181 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA1A, ADRA2A, CACNA1C, DRD2, HTR2A, KCNH2, PTGS2 |
3.06738 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, FLT3, HTR2B, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIK3CA, PIK3CB, PIM1, SRC |
3.05646 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX15, PTGES, PTGS1, PTGS2 |
3.05161 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, APP, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, KCNH2, PIK3CB |
3.03726 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
3.03611 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SLC6A4, SRC, TERT |
3.00423 |
[BP] GO:0035265 |
organ growth
|
ADRA1A, AR, CYP19A1, ESR1 |
2.99996 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, ADRA2A, CACNA1C, CYP19A1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, MMP12, SLC6A4, SRC |
2.99422 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6 |
2.97274 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, ALDH2, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
2.95576 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, APP, DRD1, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
2.95396 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, RELA, SRC |
2.95396 |
[BP] GO:0045744 |
None
|
ADRA2A, DRD2, DRD3, MET |
2.95226 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
2.95226 |
[BP] GO:0060402 |
None
|
ADRA1A, CACNA1C, DRD2, HTR2A, HTR2B |
2.95226 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
2.95226 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA1A, ADRA2A, APP, AURKB, CDC25B, DRD2, ESR1, F3, FLT3, HTR2A, HTR2B, MAP2K1, MAP3K7, PIK3CA, PIK3CB, PTPN1, SRC, TERT, XDH |
2.93907 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, APP, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PIK3CB |
2.89419 |
[BP] GO:0007568 |
aging
|
ADRA1A, AURKB, CYP1A1, HTR2A, MAP2K1, PTGS2, RELA, TERT |
2.89299 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HCAR2, HTR2B, MMP12, SLC6A4, SRC |
2.89299 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
2.89299 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
2.89299 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, APP, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PIK3CA, PIK3CB |
2.89299 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, ESR1, FLT3, HTR1A, MAP2K1, MET, PIK3CB, PIM1, SRC, TYR |
2.8874 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, FLT3, HTR2B, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, XDH |
2.86649 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, APP, DRD1, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
2.86649 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.86316 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, APP, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PIK3CB |
2.83262 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, AR, AXL, CACNA1C, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, PGR, PTGS2, SLC6A2 |
2.83262 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, HTR1A, MAP2K1, MAP3K7, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGES, PTGS1, PTGS2, PTPN1, RELA, SLC6A2, SLC6A4, SRC, TERT |
2.83019 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, APP, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PIK3CB |
2.80223 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.8002 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, ADRA2A, DRD2, MAP2K1, MAP3K7, PIK3CA, PIK3CB, PTPN1, SRC |
2.79439 |
[BP] GO:0015872 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.79439 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP2C19 |
2.79439 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, HTR6 |
2.77796 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, APP, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PIK3CB |
2.76859 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, APP, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PIK3CB |
2.74886 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, APP, DRD1, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
2.74886 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
2.74782 |
[BP] GO:0007189 |
None
|
ADRA1A, ADRA2A, DRD1, DRD2, DRD3 |
2.74782 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
2.74782 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, NR3C1, RELA, SRC |
2.74753 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.73872 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, APP, AR, AXL, CDC25B, CYP19A1, CYP1A1, DRD1, ESR1, ESRRB, HSD17B2, HSD17B3, MAP2K1, MMP2, MMP9, PGR, PTGS2, SLC6A4, SRC |
2.73145 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.70486 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
2.70486 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
2.70486 |
[BP] GO:0001516 |
None
|
PTGES, PTGS1, PTGS2 |
2.70486 |
[BP] GO:0046457 |
None
|
PTGES, PTGS1, PTGS2 |
2.70486 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.70318 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, ESR1, ESRRA, HTR5A, PTGS2, SLC6A4 |
2.68188 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
2.68188 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, ALOX15, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, XDH |
2.67931 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6 |
2.66511 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
2.66264 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2, TERT |
2.65765 |
[BP] GO:0060401 |
None
|
ADRA1A, CACNA1C, DRD2, HTR2A, HTR2B |
2.65765 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, FLT3, HTR2A, HTR2B, IGF1R, MAP2K1, MAP3K7, PIK3CB, PTPN1, SRC |
2.65765 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
2.6502 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AR, AXL, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, HSD17B3, MAP2K1, PGR, PTGS2, SRC |
2.64478 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MAP2K1, MET, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC |
2.64152 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, ADRA2A, CSNK2A1, ESRRB, HCAR2, HTR2A, HTR2B, KDR, MAP3K7, MET, PIK3CA, PIK3CB, PPARA, PTPN1, RELA |
2.62777 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, CYP1B1, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR7, KCNH2, PIK3CA, PTGS2, SLC6A4, SRC, TYR |
2.62732 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, APP, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PIK3CB |
2.62666 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.6234 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.6234 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.6234 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MAP2K1, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC |
2.61864 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
2.61781 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADRA2A, APP, CA2, CACNA1C, DRD2, DRD3, HCAR2, HTR2B, MMP12, PTGS2, PTPN1, SRC |
2.60197 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, ADRA2A, HCAR2, HTR2B, MET, PIK3CA, PPARA, RELA |
2.56991 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, ADRA2A, CACNA1C, CYP19A1, DRD2, HCAR2, HTR1A, HTR2A |
2.56991 |
[BP] GO:1901570 |
None
|
ALOX15, ALOX5, PTGES, PTGS1, PTGS2 |
2.56991 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, IGF1R, KDR, MAP2K1, MET, MMP12, NR3C1, PGR, PPARA, RELA, RORC, SRC, TERT |
2.56534 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA1A, ADRA2A, CACNA1C, DRD2, DRD3, HCAR2, HTR2A, KCNH2, PTGS2 |
2.55574 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, CYP1B1, MMP9, PTGS1, PTGS2, RELA, SRC |
2.55435 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.54194 |
[BP] GO:0051937 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.54194 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
2.53027 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
2.52003 |
[BP] GO:0043268 |
None
|
ADORA1, ADRA2A, DRD1, KCNH2 |
2.52003 |
[BP] GO:0006954 |
inflammatory response
|
ADORA1, ADORA3, ALOX15, AXL, PIK3CA, PIK3CB, PTGES, PTGS1, PTGS2, RELA |
2.50438 |
[BP] GO:1904063 |
None
|
ADRA2A, DRD2, DRD3, KCNH2, MMP9 |
2.50438 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, CYP19A1, ESR1, HSD17B2, HSD17B3, MAP2K1, SRC |
2.50246 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, HTR7, PPARA, RORC, SLC6A4 |
2.49719 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, AR, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, PGR, SLC6A2 |
2.49178 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC |
2.49178 |
[BP] GO:0051781 |
None
|
AURKB, CDC25B, DRD2, DRD3, HTR2B |
2.48554 |
[BP] GO:0050890 |
None
|
ADORA1, APP, DRD1, DRD2, DRD3, HTR2A, PTGS2, SLC6A4 |
2.48554 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX15, ALOX5, CES1, CYP19A1, CYP1A1, HSD17B3, PTGES, PTGS1, PTGS2 |
2.47913 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA1A, ADRA2A, AR, DRD2, DRD3, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, RELA, SRC, TERT, XDH |
2.47336 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.47336 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.47336 |
[BP] GO:0070920 |
None
|
ESR1, MAP2K1, TERT |
2.47336 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX15, ALOX5, PTGS2 |
2.47336 |
[BP] GO:0010959 |
None
|
ADORA1, ADRA2A, CACNA1C, DRD1, DRD2, DRD3, HTR2A, KCNH2, PTGS2 |
2.46274 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, FLT3, HTR2B, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, XDH |
2.4578 |
[BP] GO:0071396 |
cellular response to lipid
|
AR, AXL, ESR1, FLT3, NR3C1, RELA, RORC, SLC6A4, SRC |
2.45553 |
[BP] GO:0030534 |
None
|
APP, DRD1, DRD2, DRD3, HTR2A, PPARA |
2.44356 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, MET, MMP9, PPARA, SRC, TERT |
2.43157 |
[BP] GO:0060748 |
None
|
AR, PGR |
2.42217 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.42217 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.42217 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.42217 |
[BP] GO:0032227 |
negative regulation of synaptic transmission, dopaminergic
|
PTGS2, SLC6A4 |
2.42217 |
[BP] GO:0042133 |
neurotransmitter metabolic process
|
ACHE, CYP1B1, HTR1A, MAOA, SLC6A4 |
2.41204 |
[BP] GO:0055065 |
metal ion homeostasis
|
ADRA1A, APP, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, KCNH2, PIK3CB |
2.40727 |
[BP] GO:0051302 |
None
|
AURKB, CDC25B, DRD2, DRD3, ESRRB, HTR2B |
2.40727 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, ADRA2A, ALOX15, APP, AR, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, RELA, SRC, XDH |
2.40384 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, ADRA2A, CACNA1C, DRD2, DRD3, HCAR2, HTR2B, MMP12, SRC |
2.40267 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, HTR2A, MET |
2.39694 |
[BP] GO:0032845 |
None
|
ADORA1, ADRA2A, DRD2, HTR2A, HTR2B, SRC |
2.39567 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AR, AXL, CYP1A1, DRD1, ESR1, PGR, PTGS2, SLC6A4, SRC |
2.37902 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, DRD1, DRD2, DRD3, PTGS2, RELA, TYR |
2.37793 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, DRD3, HTR1A, SLC6A4 |
2.3779 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, MMP9, PTGS2, PTPN1, RELA, SRC, TERT |
2.37597 |
[BP] GO:0050433 |
None
|
ADRA2A, DRD2, DRD3, HTR2A |
2.37193 |
[BP] GO:1904062 |
None
|
ADRA2A, APP, CACNA1C, DRD1, DRD2, DRD3, KCNH2, MMP9 |
2.36089 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, SLC6A4, SRC, TERT |
2.34681 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.34545 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, DRD3 |
2.34103 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.34103 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA1A, ADRA2A, ALOX15, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SRC, TERT, XDH |
2.32214 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.30848 |
[BP] GO:0034766 |
None
|
ADRA2A, DRD2, DRD3, KCNH2, MMP9 |
2.30016 |
[BP] GO:0030100 |
regulation of endocytosis
|
ALOX15, APP, AXL, DRD2, PIK3CB, PTPN1, SRC |
2.28908 |
[BP] GO:0048545 |
response to steroid hormone
|
AR, CA2, FLT3, NR3C1, PTGS2, RELA, SRC |
2.28908 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, F3, MET, PIK3CA, PIK3CB, SRC |
2.28514 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.28432 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, MAP3K7, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
2.24436 |
[BP] GO:1901360 |
None
|
ACHE, AKR1B1, AKR1B10, AOX1, APP, AR, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2B, MAOA, MAP3K7, NR3C1, NR3C2, PGR, PPARA, PTGS2, RELA, RORC, TERT, TYR, XDH |
2.22329 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, PPARA, RORC |
2.22329 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.22212 |
[BP] GO:0071880 |
None
|
ADRA1A, ADRA2A, DRD2 |
2.22212 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, HCAR2, PPARA |
2.22165 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, AR, CYP1B1, ESR1, ESR2, MAP3K7, PIM1, RELA |
2.2212 |
[BP] GO:0019725 |
cellular homeostasis
|
ADRA1A, APP, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PIK3CA, PIK3CB |
2.22102 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, ESR1, FABP4, MAP3K7, MMP12, MMP2, PPARA, PTGS2, PTPN1, RELA, SRC |
2.21747 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
ADRA2A, APP, AXL, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MAP2K1, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, SRC |
2.21703 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, DRD3 |
2.19496 |
[BP] GO:0034763 |
None
|
ADRA2A, DRD2, DRD3, KCNH2, MMP9 |
2.19245 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ADRA1A, APP, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, PIK3CB |
2.18961 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DRD1, IGF1R, MMP2, PTGS2, RELA, SLC6A4, SRC |
2.17882 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
ADRA2A, CYP1B1, DRD2, HTR2B, MAP3K7, MMP12, PTGS2, RELA, SRC |
2.17882 |
[BP] GO:0033031 |
positive regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.17882 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.17882 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.17882 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.17882 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.17841 |
[BP] GO:0015844 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.17841 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.17841 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, APP, FLT3, HTR2A, PTPN1, SRC |
2.17682 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADRA2A, APP, AR, CACNA1C, CSNK2A1, DRD2, DRD3, HCAR2, HTR2B, MMP12, PTGS2, PTPN1, SRC, TERT |
2.17175 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX15, CES1, CYP19A1, HSD17B3, TYR |
2.16573 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.15155 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC |
2.15155 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, ALOX15, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SRC, TERT, XDH |
2.15062 |
[BP] GO:1900542 |
None
|
ADRA2A, DRD1, DRD2, DRD3, ESRRB, HTR2A, PPARA |
2.14773 |
[BP] GO:0007611 |
None
|
APP, DRD1, DRD2, DRD3, HTR2A, PTGS2, SLC6A4 |
2.13723 |
[BP] GO:0045893 |
None
|
APP, AR, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, MAP2K1, MET, MMP12, NR3C1, PGR, PPARA, RELA, RORC, SRC, TERT |
2.13321 |
[BP] GO:1903508 |
None
|
APP, AR, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, MAP2K1, MET, MMP12, NR3C1, PGR, PPARA, RELA, RORC, SRC, TERT |
2.13321 |
[BP] GO:1902680 |
None
|
APP, AR, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, MAP2K1, MET, MMP12, NR3C1, PGR, PPARA, RELA, RORC, SRC, TERT |
2.13028 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.12899 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.12899 |
[BP] GO:0050995 |
None
|
ADORA1, ADRA2A, HCAR2 |
2.12899 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, FABP3, FABP4, MET, PIK3CA, PIK3CB |
2.12289 |
[BP] GO:0007613 |
None
|
DRD1, DRD2, HTR2A, PTGS2, SLC6A4 |
2.12127 |
[BP] GO:0006140 |
None
|
ADRA2A, DRD1, DRD2, DRD3, ESRRB, HTR2A, PPARA |
2.07891 |
[BP] GO:0051953 |
None
|
ADORA1, ADRA2A, DRD2 |
2.07605 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.07605 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.07605 |
[BP] GO:0048732 |
gland development
|
AR, CSNK2A1, CYP19A1, MAP2K1, PIK3CA, RELA, TYR |
2.07142 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, RELA, SRC |
2.07013 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.05061 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.04487 |
[BP] GO:0030168 |
platelet activation
|
ADRA2A, AXL, PIK3CA, PIK3CB, SRC |
2.03638 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, FLT3, HTR2A, PTPN1, SRC |
2.03298 |
[BP] GO:0007202 |
None
|
ADRA1A, HTR2A, HTR2B |
2.02835 |
[BP] GO:0071875 |
None
|
ADRA1A, ADRA2A, DRD2 |
2.02835 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.02835 |
[BP] GO:0019229 |
None
|
ADRA1A, ADRA2A, HTR2A, PTGS2 |
2.02835 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, RELA, SRC |
2.02377 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, CACNA1C, DRD1, DRD2, ESR1, HTR2A, HTR2B |
2.01681 |
[BP] GO:0098657 |
import into cell
|
ACHE, ADORA1, ALOX15, APP, AXL, DRD2, DRD3, HTR2B, SLC6A2, SLC6A4 |
2.01576 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRA1A, ADRA2A, ALOX15, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SRC, TERT, XDH |
2.01406 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, RELA |
2.00481 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, APP, AR, AURKB, CSNK2A1, CYP2D6, DRD2, DRD3, ESR1, ESR2, ESRRA, FABP4, HTR2B, IGF1R, MET, MMP12, MMP9, NR3C1, PIK3CA, PPARA, PTGS2, PTPN1, RELA, RORC, SRC, TERT, XDH |
2.00152 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.00152 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.00152 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.00152 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.00152 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.00152 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.00152 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.00152 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, ALOX15, ALOX5, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, F3, FLT3, FUT7, HCAR2, HSD11B1, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP2, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PTGES, PTGS1, PTGS2, PTPN1, SIGMAR1, SLC6A2, SLC6A4, SRC, TERT, TYR |
5.21438 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRA1A, AKR1B1, AKR1B10, ALDH2, ALOX15, ALOX5, AOX1, APP, AR, AURKB, CA1, CA2, CA4, CA5A, CA5B, CA7, CACNA1C, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HTR2A, HTR5A, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PTGES, PTGS1, PTGS2, PTPN1, RELA, SIGMAR1, SLC6A4, SRC, TERT, TYR, XDH |
4.89922 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AXL, CA4, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SLC6A2, SLC6A4 |
4.76074 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, FLT3, HSD11B1, HSD17B2, HSD17B3, NR3C2, PTGES, PTGS1, PTGS2, PTPN1, SIGMAR1 |
4.53752 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, ALOX15, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, DRD1, DRD2, DRD3, ESR1, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTPN1, SLC6A2, SLC6A4, SRC, TERT |
4.27938 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AXL, DRD1, DRD2, DRD3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SLC6A2, SLC6A4 |
3.99457 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, ALOX15, APP, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, F3, FLT3, FUT7, HCAR2, HSD11B1, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MAOA, MET, NR3C2, PIK3CA, PIK3CB, PTGES, PTGS1, PTGS2, PTPN1, SIGMAR1, SLC6A2, SLC6A4, SRC, TYR |
3.90852 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, HSD11B1, HSD17B2, HSD17B3, NR3C2, PTGES, PTGS1, PTGS2, SIGMAR1 |
3.67967 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA1A, ADRA2A, ALOX15, APP, AXL, CA2, CA4, CA9, CACNA1C, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, PTGS2, SIGMAR1, SLC6A2, SLC6A4, SRC |
3.57908 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.28315 |
[CC] GO:0005783 |
None
|
ADORA1, APP, CA4, CES1, CES2, CYP19A1, CYP2D6, FLT3, HSD17B3, HTR5A, KDR, MAP2K1, PTGS2, PTPN1, SIGMAR1, XDH |
2.99996 |
[CC] GO:0045121 |
membrane raft
|
ADRA1A, APP, HTR2A, KDR, PTGS2, SLC6A2, SLC6A4, SRC |
2.30659 |
[CC] GO:0098857 |
membrane microdomain
|
ADRA1A, APP, HTR2A, KDR, PTGS2, SLC6A2, SLC6A4, SRC |
2.28908 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
20.4918 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
15.7881 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR, XDH |
15.7139 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, MAP3K7, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TYR, XDH |
12.4257 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALDH2, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MAOA, NQO2, PTGS1, PTGS2, TYR, XDH |
10.8889 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AR, AXL, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, SIGMAR1 |
10.3604 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PPARA, PTPN1, RORC |
10.0204 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
9.92993 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
9.67449 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, HSD17B1, NR3C1, NR3C2, PGR, RORC, SHBG |
9.51442 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AR, AXL, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, NR3C1, NR3C2, PGR, PPARA, RORC, SIGMAR1 |
9.51442 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AR, AXL, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, SIGMAR1 |
9.21668 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALDH2, ALOX15, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, F3, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTGES, PTGS1, PTGS2, PTPN1, SRC, TERT, TYR, XDH |
9.04672 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AR, AXL, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, SIGMAR1 |
8.88346 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, SLC6A4 |
8.85215 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
8.78412 |
[MF] GO:0008227 |
None
|
ADRA1A, ADRA2A, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
8.37782 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, XDH |
8.02536 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
7.82823 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2, SRC |
7.82823 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, MAP3K7, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TYR, XDH |
7.51338 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2, SRC |
7.51338 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, PGR, PPARA, RORC |
7.44662 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PGR, PPARA, RORC |
7.44662 |
[MF] GO:0048037 |
cofactor binding
|
ALDH2, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, HSD17B1, NQO2, PTGES, PTGS1, PTGS2, SRC, XDH |
7.19114 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2, TYR |
7.05375 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, SIGMAR1, SLC6A4, SRC |
6.89941 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, TYR |
6.61414 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
6.55531 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.55378 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.55378 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.46497 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.46497 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP2D6 |
6.32625 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.17062 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2C19, CYP2D6 |
5.58658 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, CBR1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, XDH |
5.4053 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
5.38619 |
[MF] GO:0099528 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
5.3251 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD17B1, NR3C1, NR3C2, PGR, PPARA, RORC, SHBG |
5.32144 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRA2A, ALDH2, AOX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RELA, RORC, SHBG, SLC6A4, SRC, TERT, XDH |
4.61296 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, IGF1R, NQO2, NR3C1, SHBG |
4.57396 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
4.57117 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
4.18108 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, DRD1, DRD2, DRD3, F3, FLT3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1 |
4.18108 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, ALDH2, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
3.97533 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
3.7249 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, ALDH2, AOX1, XDH |
3.65763 |
[MF] GO:1901338 |
None
|
ADRA2A, DRD1, DRD2, DRD3 |
3.65077 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, APP, CSNK2A1, DRD2, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, MAP3K7, MET, MMP9, NQO2, PGR, PTGS2, RELA, SLC6A4, TERT, TYR, XDH |
3.58859 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, CSNK2A1, ESRRB, FLT3, HTR2A, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, RELA, SLC6A4, SRC |
3.3007 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, ESRRB, FLT3, HTR2A, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, RELA, SLC6A4, SRC |
3.22266 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
3.16146 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
3.05161 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.00423 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB |
2.89299 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, ALDH2, AOX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP12, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RELA, RORC, SLC6A4, SRC, TERT, XDH |
2.89299 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIK3CA, PIM1, SRC |
2.89299 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, ADRA2A, DRD1, DRD2, DRD3, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
2.82371 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.8002 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.8002 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.8002 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
2.79439 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIK3CA, PIK3CB, PIM1, SRC |
2.73257 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
2.7061 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
2.70486 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.59278 |
[MF] GO:0004935 |
None
|
ADRA1A, ADRA2A, DRD2 |
2.47336 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.42217 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.42217 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.42217 |
[MF] GO:0008392 |
None
|
CYP2A13, CYP2A6, CYP2C19 |
2.40766 |
[MF] GO:0008391 |
None
|
CYP2A13, CYP2A6, CYP2C19 |
2.40766 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIK3CA, PIK3CB, PIM1, SRC |
2.40267 |
[MF] GO:0003674 |
molecular_function
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, AKR1B10, ALDH2, ALOX15, ALOX5, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPN1, RELA, RORC, SHBG, SIGMAR1, SLC6A2, SLC6A4, SRC, TERT, TYR, XDH |
2.34103 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIK3CA, PIK3CB, PIM1, SRC, TERT |
2.22329 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.22212 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADORA1, ADRA1A, ADRA2A, AOX1, AR, AXL, DRD2, FLT3, KCNH2, NQO2, PTGS2, RELA, SLC6A4, TERT, TYR, XDH |
2.21747 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, ADRA2A, AOX1, DRD2, FLT3, KCNH2, NQO2, PTGS2, RELA, SLC6A4, TERT, TYR, XDH |
2.18961 |
[MF] GO:0000978 |
None
|
AR, ESR1, ESR2, ESRRA, NR3C1, PGR, PPARA, RELA, RORC |
2.17964 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.17882 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.17882 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.17882 |
[MF] GO:0001047 |
None
|
ESR1, ESR2, ESRRB, MMP12, NR3C1, RELA |
2.09236 |
[MF] GO:0000987 |
None
|
AR, ESR1, ESR2, ESRRA, NR3C1, PGR, PPARA, RELA, RORC |
2.06739 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.00152 |